wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34111693-1BC9CC36-13F8-40DE-AD85-CB59686AA383
Q34111693-1BC9CC36-13F8-40DE-AD85-CB59686AA383
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34111693-1BC9CC36-13F8-40DE-AD85-CB59686AA383
Monoclonal antibodies: versatile platforms for cancer immunotherapy.
P2860
Q34111693-1BC9CC36-13F8-40DE-AD85-CB59686AA383
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34111693-1BC9CC36-13F8-40DE-AD85-CB59686AA383
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a817583ce58879b9c84999fc3213139ad8573066
P2860
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).